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Abstract : Several primary trials report the adjunctive value of psychoeducational interventions for improving stable an-
gina symptoms, health-related quality of life (HRQL) and psychological well-being; however, few high-quality meta-
analyses have examined the overall effectiveness of these interventions. We used meta-analysis in order to determine the 
effectiveness of psychoeducational interventions for improving symptoms, HRQL and psychological well-being in stable 
angina patients. Seven trials, involving 949 participants total were included. Those who received psychoeducation experi-
enced nearly 3 less angina episodes per week, delta ()= -2.85, 95% CI, -4.04 to -1.66, and used sublingual (SL) nitrates 
approximately 4 times less per week, = -3.69, 95% CI -5.50 to -1.89, post-intervention (3-6 months). Significant HRQL 
improvements (Seattle Angina Questionnaire) were also found for physical limitation, = 8.00, 95% CI 4.23 to 11.77, and 
disease perception, = 4.46, 95% CI 0.15 to 8.77, but CIs were broad. A pooled estimate of effect on psychological well-
being was not possible due to heterogeneity of measures. Psychoeducational interventions may significantly reduce angina 
frequency and decrease SL nitrate use in the short-term. These encouraging results must be interpreted with caution due to 
heterogeneity in methods and small samples. Larger, robust trials are needed to further determine the effectiveness of psy-
choeducation for stable angina management.  
Key Words: Stable angina, psychoeducation, angina symptoms, health-related quality of life, psychological well-being, meta-
analysis.  
INTRODUCTION 
  Chronic stable angina (CSA) pectoris is a ubiquitous and 
cardinal symptom of ischemic heart disease (IHD) character-
ized by pain or discomfort in the chest, upper abdomen, 
back, arm(s), shoulders, neck, jaw and/or teeth [1]. Angina is 
considered stable if symptoms are experienced over several 
weeks in the absence of major deterioration [2]. Stable an-
gina symptomatology can vary depending on factors such as 
demand for increased myocardial blood flow, stress, emo-
tions, diet and weather, and may range from Canadian Car-
diovascular Society (CCS) Class I to Class III angina [3].
  Evidence suggests that greater than 64% of patients with 
CSA are taking more than 1 cardiovascular drug to treat their 
symptoms [4]. Despite this, angina persists in more than 
90% of patients [5]. CSA is distressing, with a well-
documented, major negative impact on health-related quality 
of life (HRQL). Individuals with CSA often live with recur-
rent pain episodes, poor general health, impaired role func-
tioning, activity restriction, and reduced capacity for self-
care [6-18]. These patients are also at risk for acute myocar-
dial infarction, congestive heart failure, atrial fibrillation, and 
stroke [19], as well as increased risk of cardiovascular-
related mortality or hospitalization (men: RR 1.62, women: 
RR 1.48) [20].  
  Prevalence data from 1999-2002 suggest that more than 
6,500,000 Americans may be living with CSA [21]. In Scot- 
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land, CSA prevalence (April 2001-March 2002) has been 
estimated at 28/1000 men and 25/1000 women [22]. While 
the prevalence of CSA in Canada has not been studied di-
rectly, 36% of Canadians aged 35 – 64 years who reported 
having a diagnosis of heart disease in a National Population 
Health Survey (n = 345,000) reported angina symptoms and 
related daily activity restriction
a. The Canadian Laboratory 
Centre for Disease Control also found that in 1995, 16% of 
all physician visits related to heart disease in Canada (29.6 
million visits) involved a complaint of angina
b.
  CSA also imposes numerous direct and indirect societal 
costs. A recent economic pilot study by McGillion et al.
(2006, [published abstract]) found that the total median an-
nualized societal cost of CSA was $12,615 (Canadian) per 
person (2003 – 2005); indirect costs accounted for 2/3 of the 
total CSA-related cost of illness [23] In the UK, the direct 
cost of CSA in 2000, including prescriptions, admissions, 
outpatient referrals, and procedures, was estimated at 669, 
000, 000, accounting for 1.3% of the total National Health 
Service expenditure [24].  
  Considering the available data on prevalence, impact, 
health service utilization and costs, CSA is a major and de-
bilitating health problem. National guidelines are readily 
available that summarize the best evidence about pharmacol-
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ogical and percutaneous coronary interventions for improve-
ment of angina symptoms and related HRQL [25, 26]. While 
several primary studies report the value of psychoeducational 
interventions as an adjunctive means of improving CSA 
symptoms, HRQL and psychological well-being [27-33], no 
high-quality syntheses, using meta-analytic techniques, have 
been conducted to examine the effectiveness of these par-
ticular interventions. Psychoeducational interventions are 
multi-modal treatment packages that employ learning mate-
rials and cognitive-behavioural strategies to achieve changes 
in knowledge and behaviour for effective disease self-
management [34]. They target day-to-day problems that pa-
tients encounter such as pain, fatigue, decreased mobility and 
endurance, anxiety and stress [34]. Over a course of several 
days or weeks, an array of self-management techniques are 
taught that patients can rehearse and incorporate into their 
daily routines, such as a) safe exercise habits, b) energy con-
servation, pacing, and sleep quality enhancement, and c) 
communication and decision making skills. Psychoeducation 
programs can vary, ranging from individual to group-based 
formats, with either prescriptive or flexible curricula. More 
flexible programs allow for a choice of self-management 
technique(s) that best suit one’s personality, lifestyle, ability, 
and confidence level [35]. Irrespective of format, a firm 
grounding in social, cognitive and/or behavioural theories is 
critical to the success of most psychoeducation programs 
[33-40]. These theories, such as Bandura’s Self-Efficacy 
Theory, target patients’, a) confidence to achieve optimal 
functioning, b) acceptance of their chronic illness-induced 
limitations, and c) more adaptive ways of thinking, feeling 
and behaving [33-40]. A recent review of psychoeducation 
trials across divergent chronic illness populations found that 
adherence to self-efficacy enhancing principles consistently 
resulted in improved knowledge, performance of self-
management behaviours, and various aspects of physical and 
emotional functioning such as exercise capacity and mood 
status [35]. 
  To date, most psychoeducation programs designed spe-
cifically for patients with CSA have targeted confidence in 
angina self-management, reduction of angina symptoms and 
related sublingual (SL) nitrate use, as well as improvements 
in HRQL. Yet, existing reviews of these programs are either 
narrative-based [41], or have examined the effectiveness of  
a broad array of psychological interventions, with or without 
conventional cardiac rehabilitation, for general coronary 
artery disease populations [42]. 
OBJECTIVES  
  To determine the effectiveness of psychoeducational in-
terventions for improving angina symptoms, HRQL, and 
psychological well-being for patients with CSA.  
CRITERIA FOR SELECTION OF STUDIES IN-
CLUDED IN THIS REVIEW  
Study Designs  
  All published and unpublished randomized controlled 
trials of psychoeducational interventions delivered by a 
trained professional in individual or group formats, with par-
allel designs; follow up period varied. Non-randomized stud-
ies and single-group design studies were excluded.  
Participants 
  Adult outpatients of all ages with CAD and Canadian 
Cardiovascular Society Class I – III angina, experiencing 
stable symptoms for at least 6 months.  
Types of Interventions and Controls 
Psychoeducational interventions employing a combina-
tion of cognitive and behavioural angina self-management 
techniques such as energy conservation, pacing, anxiety and 
stress management or counselling, exercise, dietary planning, 
safe SL nitrate use, and relaxation training. Controls received 
routine or usual care and were not exposed to the interven-
tion during the study period.  
Outcomes Measures  
1. Angina symptom profile including angina frequency and 
duration, and related SL nitrate use  
2. Self-reported HRQL  
3. Psychological well-being, reflected by anxiety, stress 
and/or depression  
SEARCH METHODS FOR IDENTIFICATION OF 
STUDIES  
  We searched the Cochrane Central Register of Controlled 
Trials, MEDLINE, PubMed, CINHAL, EMBASE, Proquest 
Dissertation Abstracts, Psychinfo and HealthStar, Jan 1990 – 
Oct 2006, using combinations of key medical subject head-
ing (MeSH) terms including chronic stable angina, angina 
pectoris, psychoeducation, psychosocial factors, stress/pre-
vention and control, patient education, education randomized 
controlled trials, and clinical trials. We also conducted hand 
searches of relevant journals, proceedings of major confer-
ences, and secondary references; experts in the field were 
consulted for additional sources. We planned to contact 
authors where possible to obtain missing information. Our 
search strategy was critiqued and replicated by an external 
information specialist to ensure comprehensiveness.  
METHODS  
Final Selection of Trials  
Three reviewers reached consensus on all trials to be in-
cluded in this analysis by reviewing the titles, abstracts and 
reports of all trials according to the inclusion criteria speci-
fied a priori; individual trial results were not considered dur-
ing this process.  
DataExtraction and Appraisal of Methodological Quality  
  Two reviewers participated in independent extraction of 
process and outcome data from each trial according to a 
standardized format used in a prior review [41]. The quality 
of included trials was assessed by three reviewers with re-
spect to sample size, generation of randomization sequence, 
allocation concealment, standardized intervention delivery, 
reliability and validity of measurement instruments and re-
sponse rate (RR), blinding of outcome assessment, and ex-
amination of group differences.  
Data Synthesis and Analysis  
  All outcomes examined in this study were continuous in 
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ences (WMD) and associated 95% confidence intervals were 
calculated [43] using Comprehensive Meta-Analysis Version 
2, © Biostat. Inc. and verified using SAS/STAT
® SOFT-
WARE. WMDs were calculated via the inverse variance 
method wherein the weight for each primary trial was deter-
mined by the inverse of the variance of its respective effect 
estimates [43]. Mean change scores were taken from the re-
sults of each study except one (Payne et al. 1994), in which 
mean change in angina frequency had to be estimated from 
graphical output. Standard deviations for mean change 
scores were taken directly from the results where available, 
or calculated using the mean change score, the test-statistic 
(e.g. F value) and the sample size. The follow-up period for 
relevant outcomes was short-term (up to 12 weeks) for most 
trials (Bundy et al., 1994; Gallacher et al., 1997; Lewin et
al., 1995; Payne et al., 1994; McGillion et al., 2006), and 
extended to 24 weeks in one trial (Lewin et al., 2002). 
Therefore, sensitivity analyses for all outcomes were con-
ducted including and excluding the maximum follow-up 
period; length of follow-up period did not significantly affect 
the direction of pooled estimates of effects or statistical sig-
nificance.  
  With respect to angina symptom profile, one trial 
(McGillion et al. 2006 [published abstract]) did not use a 
symptom diary. Instead, the authors employed the Seattle 
Angina Questionnare (SAQ) [44] to collect 4 week angina 
frequency and nitrate use on 6 point scales where the re-
sponse categories were: 1 = 4 or more times per day; 2 = 1 to 
3 times per day; 3 = 3 or more times per week, but not every 
day; 4 = 1 to 2 times per week; 5 = less than once a week; 6 
= none over the past 4 weeks; we had access to these original 
raw data. To enable the calculation of mean differences in 
angina frequency and nitrate use for meta-analysis, partici-
pants’ responses were recoded as weekly estimates where: 1 
= 28 times per week; 2 = 14 times per week; 3 = 4 times per 
week; 4 = 2 times per week; 5 = 0.5 times per week; and 6 = 
0 times per week. The original data and the recoded data 
were analyzed for congruency in testing the association be-
tween the intervention group and the placebo group. 
Weighted mean differences were then calculated both includ-
ing and excluding this trial (McGillion et al. 2006) to exam-
ine if these approximations changed the overall conclusion; 
no impact on the significance of the results was found.  
DESCRIPTION OF STUDIES  
  Eight trials, conducted in 7 countries, between 1994 and 
2007, and involving 1,009 patients were identified for possi-
ble inclusion. One study was excluded that examined the 
impact of group psychological treatment on patients with 
non-ischemic chest pain [45]. Six of the included trials re-
ported use of an isolated psychoeducational intervention with 
components designed to enhance patients’ perceived confi-
dence and skills to manage angina symptoms (Bundy et al., 
1994; Gallacher et al., 1997; Lewin et al., 1995; 2002; Payne 
et al., 1994; McGillion et al., 2006). Control groups received 
usual medical and/or nursing care as described; no controls 
were exposed to the intervention during the study period. 
One trial included a standardized medication regimen for 
both treatment and control groups (Ma and Teng, 2005).  
  Details of each included trial are presented in Table 1.
Five trials (Bundy et al., 1994; Gallacher et al., 1997; Lewin 
et al., 1995; Payne et al., 1994; McGillion et al., 2006) 
tested small-group interventions (6-15 patients) employing 
varying combinations of educational materials, planned ex-
ercise and cognitive-behavioural techniques targeted at life-
style and symptom self-management, relaxation training or 
stress reduction, or enhancement of physical activity. Inter-
vention duration, format, and process varied. Two trials 
tested interventions with content similar to the group-based 
interventions but on an individual basis (Lewin 2002; Ma 
and Teng 2005). All trials included baseline assessment of 
participant characteristics and outcomes prior to randomiza-
tion. Most trials used symptom diaries to measure angina 
symptom profile and related SL nitrate use; objective meas-
ures of ischemia were less often used. Subjective measures 
were also most often used to examine HRQL and psycho-
logical well-being. Data pertinent to this review were col-
lected up to 24 weeks following baseline (Lewin et al., 
2002).  
METHODOLOGICAL QUALITY  
Sample sizes ranged from 29 to 452; two trials included 
power analyses to support sample size (Lewin et al., 2002; 
McGillion et al., 2006). The method of randomization was 
unclear in three trials (Bundy et al., 1994; Lewin et al., 1995; 
Ma and Teng, 2005); stated randomization methods included 
sequential envelopes (Gallacher et al., 1997), alternating 
weekly cohorts (Payne et al., 1994), external randomization 
list (Lewin et al., 2002) and centrally-controlled computer-
generated randomization (McGillion et al., 2006). Strategies 
used to preserve concealment of allocation sequence and 
blinding of outcome assessors were addressed in two trials 
(Lewin et al., 2002; McGillion et al., 2006). To varying de-
grees, all trials examined group differences in key baseline 
characteristics and pretest scores, and response rates across 
measurement occasions ranged from acceptable to excellent 
(67% - 100%). Most trials used a patient diary to record an-
gina frequency, duration, intensity and SL nitrate use; the 
reliability and validity of these tools was not addressed. 
When measured, HRQL and aspects of psychological well-
being were captured using well-established, reliable and 
valid measures. Only one trial addressed methods used to 
ensure standardized intervention delivery and adherence to 
intervention protocol (McGillion et al., 2006). Across trials, 
intervention delivery was limited to a single site; interven-
tion formats, duration, and processes were variable. The re-
sults of two trials were applicable to men only (Gallacher et
al., 1997; Payne et al., 1994). Based on our review of meth-
odological quality, the majority of available trials are likely 
susceptible to a number of biases due the following potential 
threats to validity: inadequate power (sample size bias), un-
clear allocation concealment (selection bias) and blinding of 
outcome assessment (ascertainment bias), inadequate ex-
perimental controls (co-intervention), and unknown reliabil-
ity and validity of measures (insensitive measure bias) [46-
51]. 
RESULTS  
  Seven trials, involving 949 CSA patients, were included 
in this review. It was not possible to include results from two 
trials (Gallacher et al., 1997, n = 452; Ma and Teng 2005; n 
= 100) in any pooled estimates of effect due to the heteroge-4 Current Cardiology Reviews, 2008, Vol. 4, No. 1 McGillion et al. 
Table 1.  Characteristics of Included Studies  
Study   Bundy et al. 1994 
Design   RCT  
Relevant outcomes/definitions   Angina symptoms/severity, frequency, duration, intensity; exercise capac-
ity/bicycle ergometer; anxiety and depression/HADS 
Sample size (after LTF); participant characteristics; setting; country   N= 29; male and female CSA patients aged 46-63; unclear; Clwyd, UK  
Measurement occasions; outcome measures: reliability and validity; 
RR
8 and 16 weeks post intervention; daily angina diary: not addressed, ergometer: 
not addressed, HADS: reliable and valid; 100%  
Method of randomization   Unclear  
Allocation concealment   Unclear  
Intervention   Small group 7-week (1.5 hours weekly) program on stress, anger and lifestyle 
management, problem solving, cognitive control, relaxation training; clinical 
psychologist intervener 
Blinding of outcome assessment   Unclear  
Examination of group differences   Done  
Notes   Inadequate discussion of intervention controls and description of sample 
Study   Gallacher et al. 1997 
Design   RCT  
Relevant outcomes/definitions   Chest pain and discomfort/severity, frequency, duration, intensity; stress/DSP 
Sample size (after LTF); participant characteristics; setting; country   N= 452; male CSA patients, <70 years of age, 87%; unclear; South Glamorgan, 
Wales  
Measurement occasions; outcome measures: reliability and validity; 
RR
Baseline and 6 months post-intervention; 14-day diary of chest pain and discom-
fort: not addressed, DSP: reliable and valid; 87%  
Method of randomization   Sequential groups of 8 envelopes (4 in each included in the intervention)  
Allocation concealment   Unclear  
Intervention   3 1-hour biweekly small group sessions on stress management and relaxation 
techniques; intervener not identified  
Blinding of outcome assessment   Unclear  
Examination of group differences   Done  
Notes   Inadequate discussion of intervention controls; results generalizable to men only
Study   Lewin et al. 1995  
Design   RCT 
Relevant outcomes/definitions   Angina/severity, frequency, duration, intensity, nitrate use; disability/SIP; exer-
cise tolerance/ECG treadmill test 
Sample size (after LTF); participant characteristics; setting; country   N= 65; male and female CSA patients; hospital clinic setting; England  
Measurement occasions; outcome measures: reliability and validity; 
RR
Baseline and immediate, 4 months, and 1 year post intervention; angina diary: 
not addressed, SIP: reliable and valid, ECG: reliable and valid; 87%  
Method of randomization   Unclear  
Allocation concealment   Unclear  
Intervention   8-week combined small group/individual session rehabilitation program (2 
mornings a week) featuring relaxation training, identification of mal-adaptive 
behaviours, coping strategies, goal setting; clinical psychologist and physio-
therapist interveners  Effectiveness of Psychoeducational Interventions for Improving Symptoms  Current Cardiology Reviews, 2008, Vol. 4, No. 1    5
(Table 1. Contd….) 
Blinding of outcome assessment   Unclear  
Examination of group differences   Done- extensive  
Notes   Inadequate discussion of intervention controls 
Study   Payne et al. 1994  
Design/Country   RCT 
Relevant outcomes/definitions   Chest pain/frequency and intensity likert scales; Prevailing mood and psycho-
logical stress/ CES-D, STPI 
Sample size (after LTF); participant characteristics; clinical setting; 
country  
N= 43; male veteran CSA patients < 65 years of age; unclear; USA  
Measurement occasions; outcome measures: reliability and validity; 
RR
Sessions 1 and 3, 1 and 6 months follow-up; chest pain likert scales; not ad-
dressed, CES-D and STPI: reliable and valid; 83% at 1 month, 67% at 6 months 
Method of randomization   Based on alternating weekly cohorts  
Allocation concealment   Unclear  
Intervention   3-week small group angina management program, featuring cognitive stress 
management and relaxation techniques; intervener not identified  
Blinding of outcome assessment   Unclear  
Examination of group differences   Done- extensive  
Notes   Whether allocation was random is unclear; results generalizable to men only  
Study   Lewin et al. 2002  
Design   RCT 
Relevant outcomes/definitions   Anxiety and depression/HADS; Angina/angina frequency and nitroglycerine use;
HRQL/SAQ  
Sample size (after LTF); participant characteristics; setting; country   N= 130; patients with diagnosis of angina within 1 year, average age: treatment 
66.74 (SD 9.37), controls 67.64 (9.01); outpatient clinic; England  
Measurement occasions; outcome measures: reliability and validity; 
RR
Baseline and 6 months; angina diary: not addressed, HADS and SAQ: reliable 
and valid; 91% at 6 months  
Method of randomization   Randomization by list held at a remote site  
Allocation concealment   Person responsible for randomization list blinded to patients  
Intervention   Individualized cognitive-behavioural disease management program featuring 
structured interview, patient-held workbook, audio-taped relaxation program, 
angina misconceptions, risk-factor assessment, lifestyle change, telephone sup-
port, education sessions; nurse intervener  
Blinding of outcome assessment   Done  
Examination of group differences   Done- extensive  
Notes    
Study   McGillion et al. 2006  
Design   RCT  
Relevant outcomes/definitions   HRQL/Medical Outcome Study SF-36, SAQ 
Sample size (after LTF); participant characteristics; setting; country   N=130; male and female CSA patients, average age 68 (SD 10.6); unclear; Can-
ada
Measurement occasions; outcome measures: reliability and validity; 
RR
Baseline and 3 months; SF-36 and SAQ: reliable and valid; 87%  6 Current Cardiology Reviews, 2008, Vol. 4, No. 1 McGillion et al. 
(Table 1. Contd….) 
Method of randomization   Centrally-controlled computerized randomization  
Allocation concealment   Centrally protected by computer  
Intervention   Small group 6-week self-management program featuring self-efficacy, weekly 
goal setting, energy conservation, decision making, emotional responses, symp-
tom management techniques, patient workbook, meaning of angina, safe exer-
cise, emergency management, protocol and external auditor used to ensure stan-
dardized delivery; nurse intervener  
Blinding of outcome assessment   Done  
Examination of group differences   Done- extensive  
Notes   Contact information: Dr. Michael McGillion, University of Toronto  
 Email: michael.mcgillion@utoronto.ca  
Study    Ma and Teng 2005 
Design   RCT 
Relevant outcomes/definitions   Anxiety and depression/anxiety and depression charts; angina/24 hour ambula-
tory ECG 
Sample size (after LTF); participant characteristics; setting; setting   N= 100; male and female CSA patients, age range/average not given; recruited 
in cardiology inpatient setting during medical management of angina; China  
Measurement occasions; outcome measures: reliability and validity; 
RR
Unclear; anxiety and depression charts: not addressed, 24 hour ambulatory ECG:
reliable and valid; 100%  
Method of randomization   Unclear  
Allocation concealment   Unclear  
Intervention   Standardized drug treatment applied to both groups: nitrates, anti-coagulants; 
Individualized 8- week Beck’s cognitive intervention for treatment group featur-
ing angina review; negative cognitions identification, angina misbeliefs and 
related home-based work; physician intervener  
Blinding of outcome assessment   Done  
Examination of group differences   Done  
Notes   Translated by Fang Zhang-Helwig, University of Toronto; measurement occa-
sions unclear  
NB: CES-D: Centre for Epidemiological Studies Depression Scale; DSP= Derogatis Stress Profile; ECG= electrocardiogram; HADS= Hospital Anxiety and Depression Scale; 
HRQL= health-related quality of life; RCT= randomized controlled trial; RR= response rate; SAQ= Seattle Angina Questionnaire; SD= standard deviation; SIP= Sickness Impact 
Profile; STPI= Spielberger State-Trait Personality Inventory. 
neity of their measures and analyses. A summary of the re-
sults is presented in Table 2 by outcome, and in sequential 
order, starting with symptom profiles, followed by HRQL 
and psychological well-being. Figs. 1-4 present the meta-
analysis graphs for significant outcomes respectively. All 
results pertain to pooled short-term effects, given the maxi-
mum length of follow-up of 24 weeks.  
Angina Symptom Profile  
Five trials (Bundy et al., 1994 ; Lewin et al., 1995; 2002; 
Payne et al., 1994; McGillion et al., 2006) reported on an-
gina frequency (383 patients), which we examined according 
to mean change in number of angina episodes per week. Re-
sults suggested a significant short-term reduction in angina 
frequency by 2.85 episodes per week, delta () = -2.85, 95% 
confidence interval (CI), -4.04 to -1.66, p < 0.001 (Fig. 1). 
Angina duration was reported in three trials (224 patients) 
(Bundy et al., 1994; Lewin et al., 1995; 2002) and was ex-
amined according to mean change in number of minutes per 
angina episode. Although results suggested a significant 
short-term 1/2 minute reduction in angina per episode,  = -
.51, 95% CI, -.81 to -0.21, p= 0.001, Bundy et al.’s study 
with a small sample (n = 29) carried 99% of the weight in 
this analysis due to its small standard deviation. We removed 
this study from the duration analysis given that a) it was in-
fluencing this meta-analytic result so heavily and, b) low 
variance in scores is unusual for small samples; once re-
moved, the direction of the observed effect remained un-
changed yet the summary difference in means was no longer 
significant:  = -5.86, 95% CI, -13.97 to 2.25, p= 0.001.  
  SL nitrate use was also reported in three trials (310 pa-
tients) (Lewin et al., 1995; 2002; McGillion et al. 2006) and 
was examined according to mean change in number of nitro-
glyercine uses (one use included up to 3 sprays) per week. Effectiveness of Psychoeducational Interventions for Improving Symptoms  Current Cardiology Reviews, 2008, Vol. 4, No. 1    7
Psychoeducational intervention resulted in a significant re-
duction in nitrate use by 3.69 times per week:  = -.3.69, 
95% CI, -.5.50 to -1.89, p< 0.001 (Fig. 2).  
  We could not find any clear a priori evidence of what 
constitutes clinically significant reductions in angina symp-
toms and/or sublingual nitrate use. We therefore used 
Cohen’s  d formula for standardized mean differences be-
tween groups (d = M1 - M2 / ) to calculate effect size (ES) 
as an initial indicator of clinical significance [52]. Effect size 
estimates for angina frequency and SL nitrate use were 0.49 
and 0.53 respectively.  
Health-Related Quality of Life  
  Two trials examined the impact of their interventions on 
self-reported HRQL (Lewin et al., 2002; McGillion et al., 
2006) with the disease-specific SAQ (267 patients) [43]. The 
SAQ quantifies five clinically relevant domains of disease-
specific HRQL including physical limitation (PL), anginal 
stability (AS), anginal frequency (AF), treatment satisfaction 
(TS), and disease perception (DP); no overall HRQL sum-
mary score is derived [43]. We excluded AF and AS from 
this analysis as raw SAQ AF and AS-related data (from 
McGillion et al.’s trial) were factored into our symptom pro-
file analyses. As shown in Figs. 3 and 4, results suggested 
significant improvements in PL [ = 8.00, 95% CI, 4.23 to 
11.77, p< 0.001] and DP [ = 4.46, 95% CI, 0.15 to 8.77, p= 
0.042], but CIs were wide; effect sizes were 0.51 and 0.26 
respectively. No significant improvement in TS was found. 
Psychological Well-Being  
  Three trials reported on psychological well-being using 
the Centre for Epidemiologic Studies Depression Scale and 
the Spielbeger State-Trait Personality Inventory (Payne et al.
1994), the Derogatis Stress Profile (Gallacher et al. 1997) 
and the Hospital Anxiety and Depression Scale (Lewin et al.
2002) respectively; a pooled estimate of effect on psycho-
logical well being was not possible due to the heterogeneity 
of these measures. 
Table 2.  Results  
Variable  Difference in Change   95% CI for Difference  p-value  Effect Size 
(Cohen’s d) 
Angina Symptom Profile
Angina Frequency -2.85  [-4.04,  -1.66]  <0.001  0.49 
Angina Duration
Adjusted
-0.51 
-5.86 
[-0.81, -0.21] 
[-13.97, 2.25] 
0.001 
0.157 
0.31 
0.20 
Nitroglycerine Use  -3.69 [-5.50,  -1.89]  <0.001  0.53 
Self-Reported HRQL
SAQ – DP  4.46 [0.15,  8.78]  0.042  0.26 
SAQ – PL  8.00 [4.23,  11.77]  <0.001  0.51 
SAQ - TS  2.76 [-1.47,  6.99]  0.201  0.17 
Psychological Well-Being  
Pooled estimates of effect not possible  
NB: DP= disease perception; HRQL= health-related quality of life; PL= physical limitation; SAQ= Seattle Angina Questionnaire; TS= treatment satisfaction. 
Fig. (1). WMD in frequency of angina episodes per week. 
Study name Sample size Difference in means and 95% CI
Relative 
Intervention Control weight
Bundy, 1994 14 15 6.58
Lewin, 1995 34 31 5.17
Lewin, 2002 63 67 35.89
McGillion, 2006 56 60 22.60
Payne, 1994 21 22 29.76
-15.00 -7.50 0.00 7.50 15.008 Current Cardiology Reviews, 2008, Vol. 4, No. 1 McGillion et al. 
DISCUSSION  
In this review we have appraised and summarized the 
results of 7 trials of psychoeducational interventions for CSA 
management, conducted in 6 different countries, in a variety 
of outpatient, hospital and community-based settings. The 
search strategy used to identify these trials was as compre-
hensive as possible for CSA-specific psychoeducational in-
terventions, without language restrictions.  
  The first outcome examined was angina symptom profile. 
Pooling the results of 5 of the included trials suggested that 
psychoeducational interventions significantly reduce angina 
frequency and nitrate use, and enhance aspects of disease-
specific HRQL in the short term. Angina frequency and ni-
trate use were decreased by approximately 3 and 4 times per 
week respectively. These results are encouraging given the 
high levels of perceived psychological burden and reports of 
poor quality of life associated with continued angina symp-
toms [6-18, 53, 54]. Effect size estimates for angina fre-
quency and nitrate use were 0.49 and 0.53 respectively, sug-
gesting that psychoeducation offers moderate short-term 
positive effects on these outcomes (Table 2). Although our 
pooled estimate of effect on SL nitrate use may be clinically 
significant in the context of the primary trials reviewed, 
overall reductions in nitrate use are not always desirable. 
Many patients benefit from chronic therapy via oral and/or 
transcutaneous long-acting nitrate preparations (with nitrate-
free intervals to minimize tolerance), in addition to the rou-
tine use of sublingual nitrates for acute angina episodes [55]. 
Like short-acting preparations, long-acting nitrates decrease 
cardiac workload and oxygen demand by reducing left ven-
tricular (LV) preload and afterload. In addition, they opti-
mize redistribution of blood flow to ischemic subendocar-
dium by decreasing LV end diastolic pressure and dilating 
epicardial vessels [55].  
  Education about nitrates in the included trials was limited 
to the proper administration of SL nitrates in order to man-
age acute angina. This limitation points to the need to incor-
porate and examine the effectiveness of more comprehensive 
approaches to nitrate-based angina management in future 
psychoeducation trials; recent evidence suggests that a) pa-
tients are frequently confused and/or uninformed about the 
principles of short and long-acting nitrate self-administration 
[38].  
  The second outcome was self-reported HRQL, which 
was measured in 2 trials (Lewin et al., 2002; McGillion et
al., 2006) using the disease-specific SAQ. Combined results 
of these trials suggested that psychoeducational interventions 
yield significant, small (ES = 0.26) to moderate (ES = 0.51) 
short-term improvements in the perception of the overall 
impact of heart disease on HRQL (SAQ-DP), and angina-
induced physical limitations (SAQ-PL) respectively (Table 
2). While these results were statistically significant, CIs were 
wide. In addition, the WMDs in SAQ-DP and SAQ-PL 
scores were 4.46 and 8.00 respectively; prior work has estab-
lished that minimum 5-8 point improvements across SAQ 
subscales (except the SAQ-AS scale, for which larger 
changes are clinically meaningful) are required to reflect 
clinically meaningful change in disease-specific HRQL for 
angina patients [15,44,56,57]. Therefore, only the pooled 
estimate of effect on angina-induced physical limitations 
may be of clinical significance.  
Fig. (2). WMD in sublingual nitrate usages per week. 
Fig. (3). WMD in angina-induced physical limitation (SAQ-PL) scores (disease-specific health-related quality of life). 
Study name Sample size Difference in means and 95% CI
Relative 
Intervention Control weight
Lewin, 1995 34 31 4.80
Lewin, 2002 68 74 26.51
McGillion, 2006 56 59 68.68
-25.00 -12.50 0.00 12.50 25.00
Study name Sample size Difference in means and 95% CI
Relative 
Intervention Control weight
Lewin, 2002 68 74 57.09
McGillion, 2006 56 60 42.91
-15.00 -7.50 0.00 7.50 15.00Effectiveness of Psychoeducational Interventions for Improving Symptoms  Current Cardiology Reviews, 2008, Vol. 4, No. 1    9
  The similar samples of the 2 trials, as well as their rela-
tively equal weighting (49.08%; 50.92%) and variance in 
SAQ-PL scores (Fig. 3), suggests that differences in the 
strength of their respective interventions may have been a 
key factor in their clinically sub-optimal, combined impact 
on physical functioning. One trial tested the effects of com-
munitygroup-basedpsychoeducation(McGillion et al. 2006), 
and observed greater positive short-term impact on angina-
induced physical limitations than the other trial, which exam-
ined individual counseling in a clinic setting, with supportive 
telephone follow-up (Lewin 2002). However, discrepancy in 
the end-points of these studies signals caution in making 
such inferences about the relative strengths of their interven-
tions. In addition, although there was clear overlap in con-
tent, the interventions in these studies were somewhat het-
erogeneous with respect to duration, format and process; the 
degree to which this heterogeneity negatively affected statis-
tical and/or clinical significance is unclear.  
  With respect to disease perception, it appeared that the 
individual-based clinic intervention had a more uniform im-
pact on disease perception scores (SAQ-DP) than the group-
based intervention, but to a less-positive degree on average 
(Fig. 4). High variance in scores was therefore likely a main 
contributor to the observed pooled effect on disease percep-
tion, in addition to any diluting impact that intervention het-
erogeneity may have exerted.  
  Neither trial included in HRQL analyses reported signifi-
cant positive effects on treatment satisfaction; not surpris-
ingly, the pooled effect on treatment satisfaction scores 
(SAQ-TS) was also insignificant. Beyond variance in scores 
and intervention differences, statistically insignificant results 
for treatment satisfaction (TS) at the individual trial level 
were likely primarily driven by the psychometric properties 
of the SAQ-TS scale. This scale is comprised of 3 items ori-
ented toward patient satisfaction with physician care [44]. 
Despite their differences, the interventions in both trials were 
delivered by nurses, not physicians, and the respective short-
term end points of these trials likely did not allow sufficient 
time for potential improvements in patient-physician rapport.  
  The third outcome of this review was psychological well-
being. While a number of reviews have suggested that broa-
der psychological interventions are of clinical value for pa-
tients with heart disease, there is insufficient evidence to 
make recommendations since pooled estimates of the effect 
of psychoeducation on psychological well-being were not 
possible.  
  Overall, though the meta-analytic results of this review 
appear somewhat promising for the outcomes that were 
amenable to pooled estimates of effect, they must be inter-
preted with a high level of caution. Confidence intervals, for 
HRQL in particular, were wide. The methodological quality 
of the included trials ranged from good to poor. Compre-
hensiveness in examining baseline group differences varied, 
sample sizes were generally small, and trial reports often 
lacked detail with respect to allocation concealment, out-
come assessment, reliability and validity of symptom-related 
measures, standardized intervention delivery, and experi-
mental controls. Moreover, only data from selected trials 
could be pooled to estimate combined effects on angina 
symptom profile and HRQL due to the heterogeneity of a 
number of measures used. Finally, interventions across trials 
were heterogeneous with respect to duration, format (e.g. 
individual versus group-based) and process; intervener cre-
dentials and substantive content also varied.  
Implications  
  Key questions about the effectiveness of psychoeduca-
tional interventions for patients with CSA remain unan-
swered. A common and seemingly critical element among 
these interventions was the provision of a variety of supports 
to enhance patients’ confidence and skills for angina-self-
management. Yet, the ideal intervention design that would 
yield maximal and replicable benefit for these patients is not 
known. This next step is critical to developing psychoeduca-
tion as a potential mainstay of adjunctive treatment of stable 
angina. Major and reliable improvements in HRQOL, self-
efficacy, and illness-related costs have consistently been 
reported in other complex chronic populations (e.g. arthritis, 
inflammatory bowel disease, chronic non-cancer pain), once 
ideal intervention designs have been validated [40,58,59]. 
  The sustainability of observed improvements in angina 
symptom profile and aspects of self-reported HRQL has also 
not been examined. A more comprehensive approach to edu-
cating participants about the principles of safe nitrate use, 
beyond the management of acute angina episodes, is also 
required. Each trial also used a single site to test their respec-
tive interventions. Therefore, individual trial results may   
be context-dependent and have limited generalizability. Ro-
bust multi-site trials with adequate power, standardized and 
replicable interventions, consistency in measurement, and 
longer-term follow-up are needed to avoid potential sources 
of bias and determine, more definitively, the effectiveness of 
psychoeducational interventions as an adjunctive means for 
Fig. (4). WMD in disease perception (SAQ-DP) scores (disease-specific health-related quality of life). 
Study name Sample size Difference in means and 95% CI
Relative 
Intervention Control weight
Lewin, 2002 68 74 69.17
McGillion, 2006 56 60 30.83
-15.00 -7.50 0.00 7.50 15.0010 Current Cardiology Reviews, 2008, Vol. 4, No. 1 McGillion et al. 
improving CSA symptoms, HRQL and psychological well-
being.  
SUMMARY
   CSA is a major clinical problem that poses considerable 
societal burden and deleterious impact on HRQL. While 
pooled trial results suggest that psychoeducational interven-
tions may have a positive, short term impact on angina 
symptom frequency, SL nitrate use, and aspects of self-
reported HRQL, additional well-designed trials are required 
to determine both the magnitude and sustainability of the 
effect of these interventions for CSA patients.  
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